Skip to main content
. 2023 Nov 10;8(11):e012204. doi: 10.1136/bmjgh-2023-012204

Figure 4.

Figure 4

Income group level ICERs of introducing MR-MAPs using equal discounting (A) and differential discounting (B) approaches. Equal discounting applies a 3% rate to both costs and health outcomes (averted DALYs), while differential discounting applies a 3% rate only to costs and no discounting of health outcomes. Circles and triangles denote the ICERs with the lower and upper MR-MAP prices, respectively. Colours represent the sequential (green) and accelerated (red) introduction strategies and assumptions of higher (darker) and lower (lighter) coverage projections. Horizontal dashed lines indicate the cost-effectiveness thresholds at the income group level; for scenarios with an ICER below the lines, it would be cost-effective to introduce MR-MAPs. DALY, disability-adjusted life-years; ICER, incremental cost-effectiveness ratio; MR-MAP, measles-rubella microarray patch.